Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation

Discussion The evidence base for the use of pharmacological treatments for people with borderline personality disorder is poor. In this trial we will examine the clinical and cost-effectiveness of lamotrigine to assess what if any impact offering this has on peoples’ mental health, social functioning, and use of other medication and other resources. Trial registration Current Controlled Trials ISRCTN90916365 (registered 01/08/2012)

http://link.springer.com/10.1186/s13063-015-0823-x

Source: Trials - July 18, 2015 Category: Research Source Type: clinical trials